Asgharzadeh Kangachar Sh, Mojtahedi A
Faculty of Paramedicine, Guilan University of Medical Sciences, Langroud, Iran.
Molecular and Cellular Research Center, Faculty of Medicine, Guilan University of Medical Sciences, Rasht-Iran.
Trop Biomed. 2017 Mar 1;34(1):98-109.
Significant increases in antibiotic resistance have become a critical dilemma in healthcare systems around the world. Enterobacteriaceae acquired different mechanisms of antibiotic resistance such as ESBLs production and transposon attainment, which hold antibiotic resistance genes. This may create multidrug resistant (MDR) strains. Antibiotic resistance patterns vary in different geographical regions. The present estimated-cross sectional study is aimed to determine antibiotic resistance pattern of 182 E. coli strains to 20 antibiotics. Three different methods were applied to detect the ESBL-producing E. coli. Observations revealed that oxacillin, amoxicillin and ampicillin had the lowest effect, while imipenem, gentamicin and nitrofurantoin had the highest impact on clinical E. coli strains in our region. Three different methods, including double disk synergy test (DDST) (30 mm), double disk synergy test (DDST) (20mm) and combined disk test were used to identify ESBL-producing E. coli. The prevalence of ESBL producers was at a 35.71% rate. Findings of this study indicate that there is no significant difference between these three methods in identifying ESBLproducing E. coli. There was a significant relation between ESBL production and resistance to three other classes of antibiotics, including protein synthesis inhibitor, Quinolones and Metabolite analogues. Moreover, antibiotic resistance rate in ESBL-producing E. coli was significantly higher than non ESBL- producing isolates. The MDR was at a 65.93% rate. Unfortunately, the rate of antibiotic resistance is globally increasing; this is due to several factors such as inappropriate antibiotic use, incomplete course of antibiotics use, protracted length of stay in hospitals and self-medication. Resistance mechanisms such as ESBL production and MDR cause treatment failure. Our findings suggest that ESBL production is a risk factor for MDR in clinical E. coli. Therefore, Physicians are recommended to stop excessive and long term administration of antibiotics.
抗生素耐药性的显著增加已成为全球医疗系统中的一个关键难题。肠杆菌科细菌获得了不同的抗生素耐药机制,如产生超广谱β-内酰胺酶(ESBLs)和获得转座子,这些机制携带抗生素耐药基因。这可能会产生多重耐药(MDR)菌株。不同地理区域的抗生素耐药模式各不相同。本项估计横断面研究旨在确定182株大肠杆菌对20种抗生素的耐药模式。应用三种不同方法检测产ESBL的大肠杆菌。观察结果显示,在我们地区,奥硝唑、阿莫西林和氨苄西林的效果最低,而亚胺培南、庆大霉素和呋喃妥因对临床大肠杆菌菌株的影响最大。三种不同方法,包括双纸片协同试验(DDST)(30mm)、双纸片协同试验(DDST)(20mm)和联合纸片试验,用于鉴定产ESBL的大肠杆菌。产ESBL菌的流行率为35.71%。本研究结果表明,这三种方法在鉴定产ESBL大肠杆菌方面没有显著差异。产ESBL与对其他三类抗生素(包括蛋白质合成抑制剂、喹诺酮类和代谢物类似物)的耐药之间存在显著关系。此外,产ESBL大肠杆菌的抗生素耐药率显著高于非产ESBL分离株。多重耐药率为65.93%。不幸的是,全球抗生素耐药率正在上升;这是由于多种因素造成的,如抗生素使用不当、抗生素使用疗程不完整、住院时间延长和自我用药。ESBL产生和MDR等耐药机制会导致治疗失败。我们的研究结果表明,产ESBL是临床大肠杆菌多重耐药的一个危险因素。因此,建议医生停止过度和长期使用抗生素。